(Q34099000)

31 July 2017

1 reference

title

The endocannabinoid system: a physiological perspective on its role in psychomotor control (English)

1 reference

31 July 2017

endocannabinoid system

0 references

author name string

Giuffrida A

series ordinal

1

1 reference

PubMed ID

11106788

31 July 2017

Piomelli D

series ordinal

2

1 reference

31 July 2017

1 November 2000

1 reference

Chemistry and Physics of Lipids

31 July 2017

1 reference

31 July 2017

108

1 reference

31 July 2017

1-2

1 reference

31 July 2017

151-158

1 reference

Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Control of pain initiation by endogenous cannabinoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabinoid transmission and reward-related events.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Adverse effects of cannabis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Pharmacology of cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabinoid receptors and immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Elevated endogenous cannabinoids in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabis abuse and the course of recent-onset schizophrenic disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Glutamatergic regulation of cannabinoid receptor gene expression in the caudate-putamen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

SR 141716A, a CB1 cannabinoid receptor antagonist, potentiates the locomotor stimulant effects of amphetamine and apomorphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Localization of cannabinoid receptor mRNA in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Molecular characterization of a peripheral receptor for cannabinoids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Pharmacology of cannabinoid CB1 and CB2 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Endogenous cannabinoid signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Structural determinants for recognition and translocation by the anandamide transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

The endocannabinoid system as a target for therapeutic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Role of the endogenous cannabinoid system in the regulation of motor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

The N-acylation-phosphodiesterase pathway and cell signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

A second endogenous cannabinoid that modulates long-term potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Psychiatric symptoms in cannabis users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-3084%2800%2900193-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-3084(00)00193-6

1 reference

31 July 2017

1 reference

PubMed ID

11106788